Clinical Trials

NCT Number: NCT06084338 Phase: PHASE2 Trial Summary: This trial tests if the combination of comprehensive metastasis directed therapy delivered by a precision form of external beam radiotherapy (stereotactic ablative radiotherapy), combined with PSMA ta – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): VA Office of Research and Development Acronym:

NCT Number: NCT06008483 Phase: PHASE1 Trial Summary: To determine the Maximum Tolerated Dose (MTD) of CycloSam®, Samarium-153-DOTMP (Sm-153-DOTMP), a radiopharmaceutical that delivers radiation to the bone when injected, given as a tandemly administere – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): QSAM Therapeutics, Inc. Acronym:

NCT Number: NCT06250751 Phase: NA Trial Summary: To refine a remote behavioral exercise training intervention for testing in a larger randomized trial. – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Virginia Commonwealth University Acronym: BETR-PC

NCT Number: NCT06173362 Phase: PHASE2 Trial Summary: This phase II trial compares the effects, good and/or bad of abiraterone and prednisone or darolutamide alone in treating patients with prostate cancer that may have spread from where it first started – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Mamta Parikh Acronym:

NCT Number: NCT06120491 Phase: PHASE3 Trial Summary: The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician’s choice NHA relative to placebo + physician’s choice NHA by assessment of radiographic progression-free sur – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): AstraZeneca Acronym: EvoPAR-PR01

NCT Number: NCT06205316 Phase: PHASE3 Trial Summary: This phase III trial tests the side effects of stereotactic body radiation therapy (SBRT) compared to hypofractionated radiotherapy for treating patients with prostate adenocarcinoma that has come bac – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Mayo Clinic Acronym:

NCT Number: NCT05960578 Phase: PHASE2 Trial Summary: This phase II trial tests how well golimumab and apalutamide work in treating patients with castration resistant prostate cancer. Golimumab is in a class of medications called tumor necrosis factor (T – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Washington Acronym:

NCT Number: NCT05682443 Phase: PHASE1|PHASE2 Trial Summary: The goal of this clinical trial is to examine the safety and efficacy of ONC-392 in combination with lutetium Lu 177 vipivotide tetraxetan in metastatic castration resistant prostate cancer patient wh – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): OncoC4, Inc. Acronym: PRESERVE-006

NCT Number: NCT06037863 Phase: PHASE2 Trial Summary: This clinical trial evaluates the effects of an empty bladder versus (vs.) a full bladder prior to undergoing a computed tomography (CT) simulation for radiation therapy in patients with prostate canc – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Acronym:

NCT Number: NCT06037954 Phase: NA Trial Summary: The purpose of this study is to look at mental health services for adults with depressed mood who were diagnosed with cancer at the age of 65 or older. This study will compare the usual approach for c – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): […]